Although direct evidence supporting enhanced CSF1R expression in activated microglia due to a higher demand for CSF1 is lacking, an overall CSF1R upregulation has been observed in mouse models of amyloidosis and neurotoxic models of Parkinson's disease (Murphy Jr. This evidence concerns the gene CSF1 and amyloidosis.